Cargando…
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
Progression of cancer is often associated with interactions between cancer cells and extracellular matrix (ECM) surrounding them. Increasing evidence has suggested that accumulation of hyaluronan (HA), a major component of ECM, provides a favorable microenvironment for cancer progression. Pancreatic...
Autores principales: | Sato, Norihiro, Cheng, Xiao-Bo, Kohi, Shiro, Koga, Atsuhiro, Hirata, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788704/ https://www.ncbi.nlm.nih.gov/pubmed/27006892 http://dx.doi.org/10.1016/j.apsb.2016.01.002 |
Ejemplares similares
-
Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015) -
Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma
por: Kudo, Yuzan, et al.
Publicado: (2019) -
Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2015) -
Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2013) -
4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions
por: Cheng, Xiao-Bo, et al.
Publicado: (2018)